3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Mesothelioma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Pemetrexed
3
sacituzumab govitecan
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
encorafenib
1
binimetinib
1
Vincristine
1
Sunitinib
1
Sirolimus
1
Raltegravir Potassium
1
Paclitaxel
1
One-Lung Ventilation
1
Midazolam
1
Leucovorin
1
Itraconazole
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Drug Therapy
1
Clinical Trials, Phase I as Topic
1
Cetuximab
1
Carboplatin
1
Bevacizumab
1
Anesthesia, General
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Clinical Trials, Phase I as Topic
×
Other solid neoplasm
×
Clear all
NCT03655834
2022-05-10
IMPROVE-III
Radboud University Medical Center
Phase 4
Completed
10 enrolled